PAM Stock Recent News

Pampa Energía is transforming resilience into structural expansion, advancing major projects like shale oil, LNG, and crude export despite short-term margin pressure. Q2 2025 results showed lower revenues and profits, but strategic investments and a strong balance sheet position the company for future growth. Valuation remains attractive, with Pampa Energía trading at a steep discount to global peers and its own history, while profitability and projected growth are strong.

The second quarter saw a drop in profits and a squeeze on margins, but the financial situation remains manageable, and investment in growth explains the negative cash flow. Key developments on the Rincón de Aranda position Pampa to take advantage of Vaca Muerta's export potential and reduce dependence on local gas. Shares remain an attractive long-term play, but the near term is likely volatile; execution on the Neuquen basin, tariff updates, and gas pricing are key points to follow.

I maintain a Hold rating on Pampa Energia, as most segments face stagnation and regulatory uncertainty, though oil and gas offer future growth potential. Power generation profits are peaking in USD terms, but recent FX deregulation and unclear regulation threaten future profitability and investment in this segment. Petrochemicals remain weak due to global overcapacity, while natural gas growth is delayed until LNG projects come online in 2027/28, with margins still speculative.

Pampa Energía S.A. (NYSE:PAM ) Q2 2025 Earnings Call August 7, 2025 10:00 AM ET Company Participants Gustavo Mariani - CEO, Executive VP & Vice Chairman Horacio Jorge Tomas Turri - Executive Director of Exploration & Production Lida Wang - Head of Investor Relations & Sustainability Raquel Cardasz - Corporate Participant Raquel Cardasz Good morning, everyone, and thank you for waiting.

BUENOS AIRES, ARGENTINA / ACCESS Newswire / August 6, 2025 / Pampa Energía S.A. (NYSE:PAM)(Buenos Aires Stock Exchange:PAMP), an independent company with active participation in Argentine oil, gas and electricity, announces the results for the six-month period and quarter ended on June 30, 2025.

Argentina's Pampa Energia has applied to build an oil and gas treatment plant at the Vaca Muerta shale formation, the company said on Tuesday, in a project worth $426 million.

Pampa Energía is leveraging Argentina's macro stabilization to consolidate its leadership in power and gas, while expanding regionally and investing in strategic LNG, shale oil, and renewables projects. Operational strength continues: thermal availability at 96%, PEPE 6 fully running, and Rincón de Aranda progressing fast toward 20,000 bpd. The FLNG project also confirmed with global partners. Financials remain solid with just 0.6x net debt/EBITDA, over $1.1B in cash, and strong margins. PAM funds growth without borrowing or shareholder dilution.

Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced GABAB PAM Substance use disorders program successfully through IND enabling studies Entered option agreement with Sinntaxis for an exclusive license to intellectual property covering the use of mGlu5 NAM in brain injury recovery Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 19, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its Q1 2025 financial results and provided a corporate update.

PLANO, Texas--(BUSINESS WIRE)--Diodes Incorporated (Nasdaq: DIOD) introduces the industry's first ReDriver™ to reach PCI Express® (PCIe®) 6.0 protocol speeds (up to 64 GT/s) while being backwards-compatible with PCIe 5.0/4.0/3.0 protocols. The PI3EQX64904 is a low-power, high-performance, 64GT/s, four-differential-channel, PAM4, linear ReDriver. Target applications include AI data centers (storage and servers), workstations, 5G networking, CPU-to-network (PCIe NIC card) and CPU-to-storage (NVME.

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) in multiple preclinical models of chronic cough compared to reference drugs.